Question-and-Answer SessionI'm sure we have a lot to talk about in terms of some of the updates from this week, but maybe just level set expectations in terms of what you see as the key priorities for the company right now.Dr. Christopher AnzaloneChairman, CEO & President Sure. We have a really busy 6 to 9 months ahead of us in essentially chronological order. I think what you're going to see is we will bring MAPT to the clinic. That's going to be our first CNS drug that is administered via a subcu injectio ...